US4331697A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative
Abstract A heparin derivative in which at least 0.5% of the entire hydroxyl groups of heparin are in the form of an ester of the following formula ##STR1## wherein R 1 , R 2 and R 3 each represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; a method for producing aforesaid heparin derivative which comprises reacting heparin with a halide or anhydride of an unsaturated carboxylic acid of the formula ##STR2## wherein R 1 , R 2 and R 3 are the same as defined above; and a method for imparting antithrombotic activity to a biomedical material, which comprises treating that surface of the biomedical material which makes contact with the blood with actinic light in the presence of aforesaid heparin derivative.
A method for imparting antithrombotic activity to a biomedical material, which comprises treating that surface of the biomedical material which makes contact with the blood with actinic light in the presence of a heparin derivative in which at least 0.5% of the entire hydroxyl groups of heparin are in the form of an ester of the following formula ##STR8## wherein R 1 , R 2 and R 3 each represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms.
Claim 2
Independent Claim
83 words
A method for imparting antithrombotic activity to a biomedical material, which comprises treating that surface of the biomedical material which makes contact with the blood with actinic light in the presence of a heparin derivative in which at least 0.5% of the entire hydroxyl groups of heparin are in the form of an ester of the following formula ##STR8## wherein R 1 , R 2 and R 3 each represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms.
Claim 3
Dependent Claim
18 words
The method of claim 1 wherein at least the surface of said biomedical material is a hydrophilic substance.
Claim 4
Independent Claim
67 words
A method for imparting antithrombotic activity to a biomedical material, which comprises forming at least that surface of the biomedical material which makes contact with the blood from a polymer having a carboxylic acid halide group and/or a carboxylic anhydride group in the side chain, and treating said surface with a solution of heparin wherein at least 0.5% of the entire hydroxyl groups of heparin are esterified.
Claim 5
Independent Claim
67 words
A method for imparting antithrombotic activity to a biomedical material, which comprises forming at least that surface of the biomedical material which makes contact with the blood from a polymer having a carboxylic acid halide group and/or a carboxylic anhydride group in the side chain, and treating said surface with a solution of heparin wherein at least 0.5% of the entire hydroxyl groups of heparin are esterified.
Claim 6
Dependent Claim
26 words
The method of claim 1 wherein both R 1 and R 2 are hydrogen atoms and R 3 is a hydrogen atom or a methyl group.
Claim 7
Dependent Claim
23 words
The method of claim 1 wherein the treatment with actinic light is conducted at a temperature of from -10° C. to 70° C.